Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Octane’s Medical Innovation Forum 2023: Shaping the Future of Healthcare through Entrepreneurial Intelligence

Industry experts, entrepreneurs, investors, and innovators from all areas of the medical industry are invited to attend the Octanes Medical Innovation Forum 2023 being held October 25-26, 2023, at the Irvine Marriott, Irvine, California. The two-day event is set to present a convergence of revolutionary technologies, advanced ideas, and the best industry expertise. Leveraging the […]

Pest Control Innovator SenesTech Inc. (NASDAQ: SNES) Offers Unique Solution to Tackle the Spread of Rats Amid Growing Health Concerns

Controlling rat populations and the diseases associated with them has been a concern for centuries, underlined in the public consciousness by historical plagues believed to be spread by rats, including the 14th century “Black Death” that remains the most fatal pandemic recorded in human history, causing the deaths of 75–200 million people (https://ibn.fm/DdhRa). In the […]

PaxMedica Inc. (NASDAQ: PXMD) Announces Gold Sponsorship for The BRAIN Foundation’s Synchrony Symposia 2023

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced its Gold Sponsorship of The BRAIN Foundation’s esteemed Synchrony Symposia 2023. The BRAIN Foundation supports translational research that will lead to […]

Electronic Servitor Publication Network Inc. (XESP) Uses the Power of their Intelligent Interactive Platform to Help Clients Build and Retain Revenue

The trending nature of advanced conversational intelligence has granted it a growing wave of media gravitas in recent months, including a September report by The Intelligence. The report noted that communications technology mega cap company Apple is investing “millions of dollars a day” to further develop conversational intelligence features in its products such as the […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Ongoing Diabetes Study Program to Examine its Patented DehydraTECH(TM) Technology with Launch of Human and Animal Studies for Oral GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its intention to launch new human and animal studies that will explore its patented DehydraTECH(TM) technology on glucagon-like peptide-1 (“GLP-1”) drugs for improved bioavailability, cost-effectiveness, tolerability, weight loss potential, management of diabetes and other health conditions. Regarded as a significant expansion for […]

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Makes Significant Steps in Cementing Its Position among Top Critical Mineral Explorers with PCH Project

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF), a mineral exploration with multiple rare earths and uranium projects in mining-friendly jurisdictions, including Goiás State, Brazil and Saskatchewan and Ontario, Canada, took a “significant step in cementing itself among the upper tier of critical mineral explorers,” according to company President Stephen Burega, when it entered […]

 

From Our Blog

SS Innovations International, Inc. (NASDAQ: SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach

November 6, 2026

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is seeing increased adoption of its SSi Mantra surgical robotic platform, with CEO Dr. Sudhir Srivastava telling The Motley Fool’s interviewer Rachel Warren that the company’s commercial growth reflects a combination of technological capabilities, clinical experience and affordability (https://ibn.fm/EJk05). During the interview, Srivastava […]

Rotate your device 90° to view site.